Tricourt

Tricourt.

**Contraindication** for the use of Tricort is hypersensitivity to the active substance. The drug should not be used for systemic mycoses, glaucoma, gastric and duodenal ulcers, renal dysfunction, acute hepatitis, acute renal failure, osteoporosis, acute infectious diseases, decompensated conditions of the cardiovascular system, menstrual disorders, arterial hypertension during exacerbation , severe disturbances of water and electrolyte balance, pregnancy, lactation, in children under 6 years of age. It should also be noted that the use of the drug may be accompanied by **side effects**, such as insomnia, anxiety, changes in the function of the adrenal cortex, impaired tolerance and increased blood glucose levels, possible gynecomastia, impotence, varicose veins, ulcers and vomiting, diarrhea and nausea, increased blood pressure, heart rhythm disturbances, growth retardation in children. These phenomena may be associated with prolonged use of the drug or discontinuation of its use. Tricort reduces the pituitary gland's release of ACTH, b-mimetic hormones, thyroid hormones and adrenocotropic hormone. After instillation of the drug into the eye, it causes suppression of the function of the ciliary body, increased sensitivity of photoreceptor cells and eye hyperemia. Restoration of normal function of the ciliary muscles occurs after a few days. **Overdose.** As a result of overdose, the following symptoms develop: high sugar levels, glucose, and hyperpyrexia. Treatment includes maintaining vital functions while the effect of Tricort gradually disappears and continuing the use of additional natural corticosteroid hormones. Possible infection spread by infectious agents